Stock Analysis
Intel Corporation (INTC)
NASDAQ: INTC · Semiconductors, Integrated Design and Foundry
Updated
Rated Watchlist, with a fair value of $122.60 against a last close of $101.35 (+21% implied upside). Intel fell 20% to the $92-$104 zone on sector and rate pressure while earnings estimates held, so valuation now supports interest, but the upgrade waits for 29 October results to show CPU price rises lifting gross margin.
- Verdict
- Watchlist
- Fair Value
- $122.60
- Investment Score
- 51.3/100prev 49.3
Technical read (chart only): Neutral as of Pullback inside a longer uptrend: below the 20- and 50-day averages but well above a rising 200-day; for a Watchlist name, watch whether the 20-session low near $96.50 holds and the 50-day near $103 is reclaimed, while a close below the 200-day near $83 would break the structure.The Watchlist verdict comes from the fundamentals alone. The technical read looks only at the price chart. It does not change the verdict or the score and only guides entry timing.
Investment Scorecard
Composite score 51.3/100 (previous 49.3). Every factor is scored out of 10, ten always being the best outcome, including for risk.
| Factor | Score | Weight | Change | Basis |
|---|---|---|---|---|
| Business Quality | 6/10 | 16% | unch. | Pricing power in the core CPU franchise is documented; Intel Foundry still lost $2.1bn in the June quarter. |
| Financial Strength | 5/10 | 16% | unch. | Net debt of $20.6bn at June, largely offset by the $20bn August share sale; adjusted free cash flow was negative $8.4bn in the quarter. |
| Competitive Advantage | 6/10 | 13% | unch. | 14A is ahead of its defect plan, but TSMC's talks with Terafab show the foundry win is contestable until it is written down. |
| Management | 6/10 | 10% | unch. | Guidance has been met; the 14A design kit due in October is still to be confirmed as shipped. |
| Growth Potential | 7/10 | 16% | unch. | Consensus revenue growth of about 19% in 2026 and 15% in 2027; GPU D-series adds an inference product line. |
| Valuation | 3/10 | 19% | +1 | Raised from 2. 66.7x 2026 and 48.5x 2027 consensus EPS; the price is now 17% below the weighted fair value. |
| Risk (10 = lowest risk) | 3/10 | 10% | unch. | Beta of 2.2, a Fed that may hike again, negative free cash flow and an AI-funding scare that hit the sector. |
Recent Developments
| Date | Development | Impact |
|---|---|---|
| GPU D-series inference card and Xeon 6+ rack designs Announced at the OCP Global Summit: Xe3P inference card with up to 480 GB LPDDR5X, 1.5 TB/s and 1.3 petaflops FP8 at 350 W; customer sampling under way; pricing not disclosed. Reading: A new data-centre product line aimed at inference; no revenue assumed before 2027, so no score moved. | Medium | |
| Further CPU price increases Intel confirmed increases earlier in 2026; a ~10% October rise was reported in September; trade reports of a further 15-20% round for Intel and AMD are unconfirmed. Reading: The pricing thesis is intact but its proof is the 29 October gross margin; the unconfirmed reports carry no weight. | Medium | |
| Terafab: TSMC talks alongside Intel Musk confirmed early, non-binding talks between TSMC and Terafab on 3 October; on 7 October he said Tesla and SpaceX will build and run the fab, with TSMC at most subleasing space. Intel's chief executive said Intel remains involved. Intel's economics are undisclosed. Reading: Lowers the odds of the bull case's foundry validation without removing anything from the base case, since no Terafab revenue sits in estimates; a written TSMC process commitment would cut the bull case. | Medium | |
| 14A process design kit 0.9 Management said in August the kit is due in October and 14A defect density is ahead of plan; no release announced as of 13 October. Reading: The next hard checkpoint for external foundry customers. | Medium | |
| SK hynix and the Ohio site Reported talks on US memory production possibly involving Intel's Ohio site; SK hynix says nothing is finalised; no update since. Reading: Unquantifiable until an agreement exists. | Medium | |
| Third-quarter results date Results on 29 October after the close; guidance: revenue $15.8-16.8bn, non-GAAP gross margin 42.0%, non-GAAP EPS $0.38. Reading: Sets the timing of the upgrade test. | Low | |
| Altera listing Altera, 49% owned by Intel, filed confidentially for a US listing. Reading: Intel's stake is about $4.3bn at the 2025 valuation, under 1% of market value (own calculation). | Low |
Key Risks
| Risk | Probability | Severity | Comment |
|---|---|---|---|
| Valuation | High | High | 48.5x 2027 consensus EPS even after the fall; little room for a margin miss. |
| Discount rate | High | High | 10-year yield 5.22%, 30-year 5.60% (9 Oct); a second Fed hike is in play for 27-28 October; beta of 2.2. |
| AI funding cycle | Medium | High | A report on OpenAI's revenue knocked the sector on 8 October; slower AI spending would hit server demand and pricing. |
| Pricing reversal | Medium | High | Shortage pricing is cyclical; memory costs could shrink PC volumes faster than prices rise. |
| Foundry customer | Medium | High | No named 14A customer; TSMC is now in Terafab talks. |
| Execution | Medium | High | 14A volume is a 2028 event; the design kit is the next checkpoint. |
| Cash consumption | High | Medium | Adjusted free cash flow of -$8.4bn in Q2; capex above $20bn. |
| Competition | High | Medium | AMD and Arm-based designs take share where Intel cannot supply. |
Scenario Analysis
| Case | Probability | Fair Value | Outlook |
|---|---|---|---|
| Bull | 25% | $164 to $197 | Pricing success: shortage pricing lifts 2027 EPS to about $2.52 (consensus $2.09 plus the $0.43 pricing effect from the prior analysis), gross margin moves toward the mid-40s, and a named 14A customer signs after the design kit ships. |
| Base | 50% | $105 to $125 | Consensus delivered: 2027 EPS of $2.09, part of the October price rise sticks, foundry losses narrow slowly and capex stays above $20bn. |
| Bear | 25% | $72 to $88 | Pricing failure: PC volumes fall faster than prices rise, 2027 EPS near $1.60, no external 14A customer emerges and further capital is needed. |
The Case
Would a disciplined investor put fresh money into Intel at $101.35? Not yet, though it is closer than at any point in this coverage. Consensus earnings held through a 20% fall driven by a sector sell-off, the Terafab talks and multi-decade-high yields, and the stock now sits 17% below its scenario-weighted value of about $122.60.
The single biggest concern is that the margin evidence has not arrived. If the 29 October results show CPU price rises lifting gross margin above guidance, Intel becomes a Buy in the $92-$104 zone it now occupies; if not, the right price is nearer $92.
Archived Reports
Beating The Bull keeps every past version of this report on file. Verdicts and numbers reflect what was known when each one was published.
Informational use only. Not financial advice.